1. Home
  2. UBX vs DTSS Comparison

UBX vs DTSS Comparison

Compare UBX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • DTSS
  • Stock Information
  • Founded
  • UBX 2009
  • DTSS 2014
  • Country
  • UBX United States
  • DTSS China
  • Employees
  • UBX N/A
  • DTSS N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • UBX Health Care
  • DTSS Technology
  • Exchange
  • UBX Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • UBX 13.9M
  • DTSS 16.5M
  • IPO Year
  • UBX 2018
  • DTSS N/A
  • Fundamental
  • Price
  • UBX $0.78
  • DTSS $2.00
  • Analyst Decision
  • UBX Strong Buy
  • DTSS
  • Analyst Count
  • UBX 3
  • DTSS 0
  • Target Price
  • UBX $4.67
  • DTSS N/A
  • AVG Volume (30 Days)
  • UBX 521.0K
  • DTSS 82.5K
  • Earning Date
  • UBX 08-05-2025
  • DTSS 05-14-2025
  • Dividend Yield
  • UBX N/A
  • DTSS N/A
  • EPS Growth
  • UBX N/A
  • DTSS N/A
  • EPS
  • UBX N/A
  • DTSS N/A
  • Revenue
  • UBX N/A
  • DTSS $56,255,129.00
  • Revenue This Year
  • UBX N/A
  • DTSS N/A
  • Revenue Next Year
  • UBX N/A
  • DTSS N/A
  • P/E Ratio
  • UBX N/A
  • DTSS N/A
  • Revenue Growth
  • UBX N/A
  • DTSS 144.20
  • 52 Week Low
  • UBX $0.66
  • DTSS $1.63
  • 52 Week High
  • UBX $3.10
  • DTSS $7.67
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.12
  • DTSS 40.28
  • Support Level
  • UBX $0.67
  • DTSS $1.91
  • Resistance Level
  • UBX $0.83
  • DTSS $2.18
  • Average True Range (ATR)
  • UBX 0.09
  • DTSS 0.14
  • MACD
  • UBX 0.01
  • DTSS -0.03
  • Stochastic Oscillator
  • UBX 24.67
  • DTSS 15.09

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: